Innate Pharma SA (IPHYF)
2.13
-0.52
(-19.62%)
USD |
OTCM |
May 03, 16:00
Innate Pharma Market Cap: 172.19M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 172.19M |
May 02, 2024 | 214.23M |
May 01, 2024 | 214.23M |
April 30, 2024 | 214.23M |
April 29, 2024 | 214.23M |
April 26, 2024 | 214.23M |
April 25, 2024 | 214.23M |
April 24, 2024 | 214.23M |
April 23, 2024 | 214.23M |
April 22, 2024 | 214.23M |
April 19, 2024 | 214.23M |
April 18, 2024 | 214.23M |
April 17, 2024 | 214.23M |
April 16, 2024 | 214.23M |
April 15, 2024 | 214.23M |
April 12, 2024 | 214.23M |
April 11, 2024 | 214.23M |
April 10, 2024 | 214.23M |
April 09, 2024 | 214.23M |
April 08, 2024 | 214.23M |
April 05, 2024 | 214.23M |
April 04, 2024 | 214.23M |
April 03, 2024 | 214.23M |
April 02, 2024 | 214.23M |
April 01, 2024 | 208.57M |
Date | Value |
---|---|
March 28, 2024 | 208.57M |
March 27, 2024 | 189.21M |
March 26, 2024 | 193.62M |
March 25, 2024 | 193.62M |
March 22, 2024 | 193.62M |
March 21, 2024 | 193.62M |
March 20, 2024 | 193.62M |
March 19, 2024 | 193.62M |
March 18, 2024 | 197.25M |
March 15, 2024 | 197.25M |
March 14, 2024 | 197.25M |
March 13, 2024 | 197.25M |
March 12, 2024 | 197.25M |
March 11, 2024 | 197.25M |
March 08, 2024 | 203.72M |
March 07, 2024 | 203.72M |
March 06, 2024 | 203.72M |
March 05, 2024 | 229.59M |
March 04, 2024 | 229.59M |
March 01, 2024 | 229.59M |
February 29, 2024 | 229.59M |
February 28, 2024 | 229.59M |
February 27, 2024 | 229.59M |
February 26, 2024 | 229.59M |
February 23, 2024 | 229.59M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
154.19M
Minimum
Sep 29 2022
624.30M
Maximum
Sep 17 2021
330.98M
Average
297.91M
Median
Mar 16 2020
Market Cap Benchmarks
DBV Technologies SA | 127.29M |
Cellectis SA | 239.61M |
PHAXIAM Therapeutics SA (DELISTED) | -- |
Genfit SA | 184.49M |
Market Cap Related Metrics
PS Ratio | 3.04 |
Price to Book Value | 3.001 |
Price | 2.13 |
Earnings Yield | -4.54% |